Germline copy number variation and cancer risk

Current Opinion in Genetics and Development

Volumn 20, Issue 3, 2010, Pages 282-289

  Kuiper, Roland P ^a   Ligtenberg, Marjolijn J L ^a   Hoogerbrugge, Nicoline ^a   Geurts van Kessel, Ad ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER FAMILY; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME INVERSION; COPY NUMBER VARIATION; DNA DAMAGE; DNA METHYLATION; FAMILIAL DISEASE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; HUMAN GENOME; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; MUTATION; NEOPLASM; RISK FACTOR;

GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GERM-LINE MUTATION; HUMANS; MUTATION; NEOPLASMS; RISK FACTORS;

EID: 77953610430     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2010.03.005     Document Type: Review

References (82)

1. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323:643-646.
2. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
3. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
4. Fredman D., White S.J., Potter S., Eichler E.E., Den Dunnen J.T., Brookes A.J. Complex SNP-related sequence variation in segmental genome duplications. Nat Genet 2004, 36:861-866.
5. Tenesa A., Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009, 10:353-358.
6. Tomlinson I.P., Dunlop M., Campbell H., Zanke B., Gallinger S., Hudson T., Koessler T., Pharoah P.D., Niittymäkix I., Tuupanenx S., et al. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer 2010, 102:447-454.
7. Tuupanen S., Turunen M., Lehtonen R., Hallikas O., Vanharanta S., Kivioja T., Björklund M., Wei G., Yan J., Niittymäki I., et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009, 41:885-890.
8. Pomerantz M.M., Ahmadiyeh N., Jia L., Herman P., Verzi M.P., Doddapaneni H., Beckwith C.A., Chan J.A., Hills A., Davis M., et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009, 41:882-884.
9. Frayling I.M., Beck N.E., Ilyas M., Dove-Edwin I., Goodman P., Pack K., Bell J.A., Williams C.B., Hodgson S.V., Thomas H.J., et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A 1998, 95:10722-10727.
10. Lipkin S.M., Rozek L.S., Rennert G., Yang W., Chen P.C., Hacia J., Hunt N., Shin B., Fodor S., Kokoris M., et al. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet 2004, 36:694-699.
11. Fearnhead N.S., Wilding J.L., Winney B., Tonks S., Bartlett S., Bicknell D.C., Tomlinson I.P., Mortensen N.J., Bodmer W.F. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A 2004, 101:15992-15997.
12. Meijers-Heijboer H., van den Ouweland A., Klijn J., Wasielewski M., de Snoo A., Oldenburg R., Hollestelle A., Houben M., Crepin E., van Veghel-Plandsoen M., et al. Low-penetrance susceptibility to breast cancer due to CHEK2, 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002, 31:55-59.
13. Seal S., Thompson D., Renwick A., Elliott A., Kelly P., Barfoot R., Chagtai T., Jayatilake H., Ahmed M., Spanova K., et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006, 38:1239-1241.
14. Rahman N., Seal S., Thompson D., Kelly P., Renwick A., Elliott A., Reid S., Spanova K., Barfoot R., Chagtai T., et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007, 39:165-167.
15. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
16. McMullan D.J., Bonin M., Hehir-Kwa J.Y., de Vries B.B., Dufke A., Rattenberry E., Steehouwer M., Moruz L., Pfundt R., de Leeuw N., et al. Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study. Hum Mutat 2009, 30:1082-1092.
17. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., Shapero M.H., de Bakker P.I., Maller J.B., Kirby A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008, 40:1166-1174.
18. Conrad D.F., Hurles M.E. The population genetics of structural variation. Nat Genet 2007, 39:S30-S36.
19. Conrad D.F., Pinto D., Redon R., Feuk L., Gokcumen O., Zhang Y., Aerts J., Andrews T.D., Barnes C., Campbell P., et al. Origins and functional impact of copy number variation in the human genome. Nature 2009, October 7 [Epub ahead of print].
20. Nguyen D.Q., Webber C., Hehir-Kwa J., Pfundt R., Veltman J., Ponting C.P. Reduced purifying selection prevails over positive selection in human copy number variant evolution. Genome Res 2008, 18:1711-1723.
21. Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., et al. Signatures of mutation and selection in the cancer genome. Nature 2010, 463:893-898.
22. Korbel J.O., Urban A.E., Affourtit J.P., Godwin B., Grubert F., Simons J.F., Kim P.M., Palejev D., Carriero N.J., Du L., et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007, 318:420-426.
23. Hinds D.A., Kloek A.P., Jen M., Chen X., Frazer K.A. Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 2006, 38:82-85.
24. Locke D.P., Sharp A.J., McCarroll S.A., McGrath S.D., Newman T.L., Cheng Z., Schwartz S., Albertson D.G., Pinkel D., Altshuler D.M., Eichler E.E. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 2006, 79:275-290.
25. McCarroll S.A., Huett A., Kuballa P., Chilewski S.D., Landry A., Goyette P., Zody M.C., Hall J.L., Brant S.R., Cho J.H., et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008, 40:1107-1112.
26. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R.J., Freedman B.I., Quinones M.P., Bamshad M.J., et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440.
27. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., Giardina E., Stuart P.E., Nair R., Helms C., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009, 41:211-215.
28. Liu W., Sun J., Li G., Zhu Y., Zhang S., Kim S.T., Sun J., Wiklund F., Wiley K., Isaacs S.D., et al. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res 2009, 69:2176-2179.
29. Thean L.F., Loi C., Ho K.S., Koh P.K., Eu K.W., Cheah P.Y. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosomes Cancer 2010, 49:99-106.
30. Diskin S.J., Hou C., Glessner J.T., Attiyeh E.F., Laudenslager M., Bosse K., Cole K., Mossé Y.P., Wood A., Lynch J.E., et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009, 459:987-991.
31. Petrij-Bosch A., Peelen T., van Vliet M., van Eijk R., Olmer R., Drüsedau M., Hogervorst F.B., Hageman S., Arts P.J., Ligtenberg M.J., et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997, 17:341-345.
32. Bunyan D.J., Eccles D.M., Sillibourne J., Wilkins E., Thomas N.S., Shea-Simonds J., Duncan P.J., Curtis C.E., Robinson D.O., Harvey J.F., Cross N.C. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 2004, 91:1155-1159.
33. Montagna M., Dalla Palma M., Menin C., Agata S., De Nicolo A., Chieco-Bianchi L., D'Andrea E. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003, 12:1055-1061.
34. Casilli F., Tournier I., Sinilnikova O.M., Coulet F., Soubrier F., Houdayer C., Hardouin A., Berthet P., Sobol H., Bourdon V., et al. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006, 43:e49.
35. Richards F.M., Phipps M.E., Latif F., Yao M., Crossey P.A., Foster K., Linehan W.M., Affara N.A., Lerman M.I., Zbar B., et al. Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993, 2:879-882.
36. Michils G., Tejpar S., Thoelen R., van Cutsem E., Vermeesch J.R., Fryns J.P., Legius E., Matthijs G. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mut 2005, 25:125-134.
37. Aretz S., Stienen D., Uhlhaas S., Stolte M., Entius M.M., Loff S., Back W., Kaufmann A., Keller K.M., Blaas S.H., et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 2007, 44:702-709.
38. Calva-Cerqueira D., Chinnathambi S., Pechman B., Bair J., Larsen-Haidle J., Howe J.R. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet 2009, 75:79-85.
39. van Hattem W.A., Brosens L.A., de Leng W.W., Morsink F.H., Lens S., Carvalho R., Giardiello F.M., Offerhaus G.J. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut 2008, 57:623-627.
40. Nystrom-Lahti M., Kristo P., Nicolaides N.C., Chang S.Y., Aaltonen L.A., Moisio A.L., Jarvinen H.J., Mecklin J.P., Kinzler K.W., Vogelstein B. Founding mutations and alu-mediated recombination in hereditary colon cancer. Nat Med 1995, 1:1203-1206.
41. Wijnen J., van der Klift H., Vasen H., Khan P.M., Menko F., Tops C., Meijers Heijboer H., Lindhout D., Møller P., Fodde R. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998, 20:326-328.
42. Plaschke J., Rüschoff J., Schackert H.K. Genomic rearrangements of hMSH6 contribute to the genetic predisposition in suspected hereditary non-polyposis colorectal cancer syndrome. J Med Genet 2003, 40:597-600.
43. Overbeek L.I., Kets C.M., Hebeda K.M., Bodmer D., van der Looij E., Willems R., Goossens M., Arts N., Brunner H.G., van Krieken J.H., et al. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Br J Cancer 2007, 96:1605-1612.
44. Oliveira C., Senz J., Kaurah P., Pinheiro H., Sanges R., Haegert A., Corso G., Schouten J., Fitzgerald R., Vogelsang H., et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009, 18:1545-1555.
45. Lesueur F., de Lichy M., Barrois M., Durand G., Bombled J., Avril M.F., Chompret A., Boitier F., Lenoir G.M., et al. The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer 2008, 99:364-370. French Familial Melanoma Study Group.
46. Cybulski C., Wokołorczyk D., Huzarski T., Byrski T., Gronwald J., Górski B., Debniak T., Masojć B., Jakubowska A., van de Wetering T., et al. A deletion in CHEK2 of 5,395bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 2007, 102:119-122.
47. Ligtenberg M.J.L., Kuiper R.P., Chan T.L., Goossens M., Hebeda K.M., Voorendt M., Lee T.Y.H., Bodmer D., Hoenselaar E., Hendriks-Cornelissen S.J., et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 2009, 41:112-117.
48. Vink G.R., White S.J., Gabelic S., Hogendoorn P.C., Breuning M.H., Bakker E. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations. Eur J Hum Genet 2005, 13:470-474.
49. Levran O., Diotti R., Pujara K., Batish S.D., Hanenberg H., Auerbach A.D. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat 2005, 25:142-149.
50. Ahvenainen T., Lehtonen H.J., Lehtonen R., Vahteristo P., Aittomäki K., Baynam G., Dommering C., Eng C., Gruber S.B., Grönberg H., et al. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 2008, 183:83-88.
51. Kikuchi M., Ohkura N., Yamaguchi K., Obara T., Tsukada T. Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1. Cancer Lett 2004, 208:81-88.
52. Riva P., Corrado L., Natacci F., Castorina P., Wu B.L., Schneider G.H., Clementi M., Tenconi R., Korf B.R., Larizza L. NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 2000, 66:100-109.
53. Bausch B., Borozdin W., Neumann H.P. Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med 2006, 354:2729-2731. European-American Pheochromocytoma Study Group.
54. Tsilchorozidou T., Menko F.H., Lalloo F., Kidd A., De Silva R., Thomas H., Smith P., Malcolmson A., Dore J., Madan K., et al. Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2. J Med Genet 2004, 41:529-534.
55. Horvath A., Bossis I., Giatzakis C., Levine E., Weinberg F., Meoli E., Robinson-White A., Siegel J., Soni P., Groussin L., et al. Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res 2008, 14:388-395.
56. Shimkets R., Gailani M.R., Siu V.M., Yang-Feng T., Pressman C.L., Levanat S., Goldstein A., Dean M., Bale A.E. Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients. Am J Hum Genet 1996, 59:417-422.
57. Bremner R., Du D.C., Connolly-Wilson M.J., Bridge P., Ahmad K.F., Mostachfi H., Rushlow D., Dunn J.M., Gallie B.L. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet 1997, 61:556-570.
58. Preudhomme C., Renneville A., Bourdon V., Philippe N., Roche-Lestienne C., Boissel N., Dhedin N., André J.M., Cornillet-Lefebvre P., Baruchel A., et al. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood 2009, 113:5583-5587.
59. Jongmans M.C., Kuiper R.P., Carmichael C.L., Wilkins E.J., Dors N., Carmagnac A., Schouten-van Meeteren A.Y., Li X., Stankovic M., Kamping E., et al. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. Leukemia 2010, 24:242-246.
60. Cascon A., Montero-Conde C., Ruiz-Llorente S., Mercadillo F., Leton R., Rodriguez-Antona C., Martinez-Delgado B., Delgado M., Diez A., Rovira A., et al. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?. Genes Chromosomes Cancer 2006, 45:213-219.
61. Baysal B.E., Willett-Brozick J.E., Filho P.A., Lawrence E.C., Myers E.N., Ferrell R.E. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004, 41:703-709.
62. McWhinney S.R., Pilarski R.T., Forrester S.R., Schneider M.C., Sarquis M.M., Dias E.P., Eng C. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 2004, 89:5694-5699.
63. Swensen J.J., Keyser J., Coffin C.M., Biegel J.A., Viskochil D.H., Williams M.S. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 2009, 46:68-72.
64. Le Meur N., Martin C., Saugier-Veber P., Joly G., Lemoine F., Moirot H., Rossi A., Bachy B., Cabot A., Joly P., Frebourg T. Complete germline deletion of the STK11 gene in a family with Peutz-Jeghers syndrome. Eur J Hum Genet 2004, 12:415-418.
65. Bougeard G., Brugieres L., Chompret A., Gesta P., Charbonnier F., Valent A., Martin C., Raux G., Feunteun J., Bressac-de Paillerets B., Frebourg T. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 2003, 22:840-846.
66. Bougeard G., Sesboue R., Baert-Desurmont S., Vasseur S., Martin C., Tinat J., Brugieres L., Chompret A., de Paillerets B.B., Stoppa-Lyonnet D., et al. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 2008, 45:535-538.
67. Kozlowski P., Roberts P., Dabora S., Franz D., Bissler J., Northrup H., Au K.S., Lazarus R., Domanska-Pakiela D., Kotulska K., et al. Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 2007, 121:389-400.
68. Huff V., Miwa H., Haber D.A., Call K.M., Housman D., Strong L.C., Saunders G.F. Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am J Hum Genet 1991, 48:997-1003.
69. Bodmer D., Ligtenberg M.J., van der Hout A.H., Gloudemans S., Ansink K., Oosterwijk J.C., Hoogerbrugge N. Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of 'easy to apply' probability models. Br J Cancer 2006, 95:757-762.
70. Vasen H.F., Mecklin J.P., Khan P.M., Lynch H.T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991, 34:424-425.
71. Vasen H.F., Watson P., Mecklin J.P., Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453-1456.
72. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., Henson D.E., Jass J.R., Khan P.M., Lynch H., Perucho M., Smyrk T., Sobin L., Srivastava S. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997, 89:1758-1762.
73. Kievit W., de Bruin J.H., Adang E.M., Ligtenberg M.J., Nagengast F.M., van Krieken J.H., Hoogerbrugge N. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet 2004, 65:308-316.
74. Kuiper R.P., Vreede L., Venkatachalam R., Ricketts C., Kamping E., Verwiel E., Govaerts L., Debiec-Rychter M., Lerut E., van Erp F., et al. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer. Cancer Genet Cytogenet 2009, 195:105-111.
75. Shlien A., Tabori U., Marshall C.R., Pienkowska M., Feuk L., Novokmet A., Nanda S., Druker H., Scherer S.W., Malkin D. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A 2008, 105:11264-11269.
76. Venkatachalam R., Ligtenberg M.J., Hoogerbrugge N., Geurts van Kessel A., Kuiper R.P. Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms. Cytogenet Genome Res 2008, 123:188-194.
77. Chan T.L., Yuen S.T., Kong C.K., Chan Y.W., Chan A.S., Ng W.F., Tsui W.Y., Lo M.W., Tam W.Y., Li V.S., Leung S.Y. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006, 38:1178-1183.
78. Winter M.J., Nagtegaal I.D., van Krieken J.H., Litvinov S.V. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 2003, 163:2139-2148.
79. Niessen R.C., Hofstra R.M., Westers H., Ligtenberg M.J., Kooi K., Jager P.O., de Groote M.L., Dijkhuizen T., Olderode-Berends M.J., Hollema H., et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 2009, 48:737-744.
80. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21:5427-5440.
81. Tufarelli C., Stanley J.A., Garrick D., Sharpe J.A., Ayyub H., Wood W.G., Higgs D.R. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 2003, 34:157-165.
82. Ruivenkamp C.A., van Wezel T., Zanon C., Stassen A.P., Vlcek C., Csikós T., Klous A.M., Tripodis N., Perrakis A., Boerrigter L., et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 2002, 31:295-300.